This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignees: The General Hospital Corporation, Avicena Group, Inc., Other. Active years: 1998-2007.
Location History:
- Boston, MA (US) (1998 - 2004)
- New York, NY (US) (2007)
Company Filing History:
4 out of 3,067 
1 out of 4 
1 out of 834,307 Years Active: 1998-2007
Title: **M Flint Beal: Innovative Solutions for Nervous System Diseases**
Introduction
M Flint Beal is a prominent inventor based in New York, NY, who has made significant contributions to the field of medical science. With a total of five patents to his name, Beal's work primarily focuses on using creatine compounds to treat various diseases of the nervous system. His innovative approach positions him as a notable figure in the world of medical research and pharmaceuticals.
Latest Patents
Beal's most recent patent outlines the therapeutic applications of creatine and creatine analogs for addressing diseases related to the nervous system. This invention emphasizes the efficacy of creatine compounds, such as creatine, creatine phosphate, and cyclocreatine, in treating conditions including diabetic neuropathies, Alzheimer's disease, Parkinson's disease, and multiple sclerosis. The patent details multiple mechanisms of action, highlighting the potential of these compounds as effective agents against a wide range of neurodegenerative disorders.
Career Highlights
Throughout his career, M Flint Beal has aligned himself with reputable institutions, including the General Hospital Corporation, where he has contributed to groundbreaking research. His dedication to advancing medical science through innovations has resulted in several patents that could reshape therapeutic strategies for neurological diseases.
Collaborations
In the realm of collaborative research, Beal has worked alongside distinguished colleagues, such as Rima Kaddurah-Daouk and Ghaleb Daouk. These partnerships have enhanced the depth and breadth of his research, expanding the knowledge surrounding creatine and its potential therapeutic uses.
Conclusion
M Flint Beal's inventive spirit and commitment to improving health outcomes through his patents exemplify the impact of innovation in medicine. By focusing on the intricacies of the nervous system and utilizing creatine compounds, Beal has taken significant strides toward developing effective treatments for debilitating diseases. His contributions exemplify the power of innovation in addressing medical challenges and improving patient care.